Verizon vs Salesforce, Blue Origin's Test, Robot Marathon | Signüll, Ethan Ding, Matt McKinney, Errik Anderson, Pippa Lamb & James Wise
Verizon vs Salesforce, Blue Origin's Test, Robot Marathon | Signüll, Ethan Ding, Matt McKinney, Errik Anderson, Pippa Lamb & James Wise
Podcast1 hr 49 min
Listen to Episode
Note: AI-generated summary based on third-party content. Not financial advice. Read more.
Quick Insights

Investors should consider Verizon (VZ) as a defensive infrastructure play, as its ownership of physical spectrum and cell towers protects it from software-related AI disruption while the company aggressively cuts $9 billion in costs. For a high-growth physical asset, The Sphere (SPHR) has outperformed major tech stocks by 442% over the last year and offers a unique global expansion thesis for "proprietary stadium technology." While Salesforce (CRM) is down 28% year-to-date, it represents a contrarian opportunity if its new Agent Force and upcoming Agent Albert platforms successfully pivot the business from "per-seat" pricing to autonomous AI value. High-risk investors may find a buying opportunity in AST SpaceMobile (ASTS) following a 16% dip caused by a satellite launch failure, as the loss is expected to be covered by insurance. Finally, watch the Tech Bio sector for acquisition activity, as "Big Pharma" is currently sitting on record cash reserves to buy AI-driven drug development firms.

Detailed Analysis

Based on the transcript from TBPN by John Coogan & Jordi Hays, here are the investment insights and asset analyses extracted from the discussion.


Salesforce (CRM)

• CEO Mark Benioff is aggressively pushing back against the "SaaS-pocalypse" narrative (the idea that AI will decimate seat-based software models). • Key Product: Agent Force (launched 2024) currently has 23,000 users out of a 150,000 customer base (~15% adoption). • Upcoming Catalyst: Agent Albert, a new AI platform that studies users and takes autonomous actions, is slated for release by the end of 2026. • Financials: Revenue growth has decelerated from 36% in 2012 to ~10% currently, though recent quarters show a slight re-acceleration (from 8.7% to 10.8%). • Stock Performance: The stock is down 28% year-to-date, performing better than many smaller SaaS peers which are down nearly 50%.

Takeaways

Contrarian Bull Case: Benioff argues that AI makes Salesforce more valuable because customers cannot easily "vibe code" (AI-generate) complex CRM systems that require high security and compliance. • Risk Factor: The "per-seat" business model is under threat if AI agents allow companies to downsize their workforce significantly. • Watch Item: Monitor "Agent Albert" and customer testimonials (like Jason Lemkin’s) to see if AI tools are actually driving ROI or just adding complexity.


Verizon (VZ)

• CEO Dan Schulman holds a "doom-pilled" view on AI, predicting 20% to 30% unemployment within the next 2–5 years due to AI and humanoid robots. • Cost Cutting: Verizon is seeking to cut $9 billion in costs and recently announced 13,000 layoffs (over 10% of its 90,000 workforce). • Strategic Moat: Unlike software companies, Verizon is insulated from the SaaS-pocalypse because it owns physical assets: spectrum allocation and cell towers.

Takeaways

Defensive Play: The stock is up 15% year-to-date and is viewed as a stable "utility" play. Phone/Internet bills are highly inelastic; customers are unlikely to "vibe code" their own cellular networks. • Internal AI Use: The company is using AI to streamline its massive internal bureaucracy and customer service (e.g., handling 8,000+ employee responses). • Investment Sentiment: Verizon is positioned as a resilient infrastructure play in an uncertain AI labor market.


AST SpaceMobile (ASTS)

• A recent launch of a satellite via Blue Origin’s New Glenn rocket resulted in an "off-nominal orbit." • The satellite was deployed too low to sustain operations and will be taken out of orbit.

Takeaways

Short-term Volatility: The stock traded down 16% overnight following the news but recovered to a 6% loss by the next day. • Risk Mitigation: The company stated the cost of the failed satellite is expected to be covered by insurance. • Long-term Outlook: Despite the setback, the "retail army" remains bullish, viewing this as a standard hurdle in the ramp-up of commercial space operations.


The Sphere (SPHR)

• Discussed as a "white pill" for physical architecture and real-world technology. • Performance: Over the last 12 months, the stock is up 442%, significantly outperforming even NVIDIA (up ~100% in the same period).

Takeaways

New Asset Class: Analysts suggest the Sphere represents a "proprietary technology for a new kind of stadium" that captures value by being a unique, non-scalable physical experience. • Expansion Potential: The "Sphere in every major city" thesis suggests a massive growth runway if the model is replicated globally.


Investment Themes & Sectors

1. The "SaaS-pocalypse" vs. Resilience

The Bear Case: AI agents will replace human workers, leading to fewer "seats" sold for software like Salesforce, Zendesk, or HubSpot. • The Bull Case: Revenue data for companies like Snowflake (30% growth), Cloudflare (34%), and GitLab (23%) suggests that the "death of SaaS" is not yet showing up in the numbers.

2. Humanoid Robotics (China vs. US)

China's Lead: Recent reports show a Chinese humanoid robot beat the human world record for a half-marathon (50 mins 26 seconds). • Manufacturing Moat: While the US leads in "brains" (chips/AI), China is dominating the manufacturing ecosystem for robot "bodies."

3. Tech Bio & Infrastructure

Alloy Therapeutics (Private - Series E): Highlighting a shift toward "AWS for drug development." • Trend: Big Pharma is sitting on record cash piles to acquire smaller AI-driven biotech firms to solve "revenue cliffs" as patents expire. • Insight: The "Tech Bio" sector is moving from pure simulation (in silico) back to "closing the loop" with physical wet labs.

4. Sovereign AI (United Kingdom)

UK Sovereign AI Fund: A £500 million fund designed to provide UK startups with compute (supercomputers), data sets, and government procurement contracts. • Strategy: The UK aims to be an "AI maker, not an AI taker," focusing on life sciences and physics rather than consumer social apps.

Ask about this postAnswers are grounded in this post's content.
Episode Description
(00:27) - Verizon vs Salesforce (25:23) - Blue Origin's Test (30:03) - Robot Marathon (32:59) - Signull is an anonymous technologist and entrepreneur focused on integrating agentic AI into consumer software. He discusses the development of an AI-driven home screen replacement for iPhones, aiming to transform static interfaces into dynamic, personalized experiences by leveraging ambient AI. He also addresses the challenges of monetization, considering ad-supported models, and reflects on the complexities of maintaining anonymity in the tech industry. (55:03) - Ethan Ding, co-founder and CEO of TextQL, a startup specializing in AI-driven data analytics, discusses the company's inception in late 2022 and its evolution in addressing enterprise data challenges. He highlights the complexities large organizations face with fragmented data systems and the substantial costs associated with migrating to new platforms. Ding emphasizes TextQL's mission to create solutions that seamlessly integrate with existing infrastructures, enabling efficient analytics without the need for costly migrations. (01:04:14) - Matt McKinney, co-founder and CEO of Loop, leverages his background in data science and engineering to revolutionize supply chain operations. He discusses how Loop utilizes AI to automate back-office processes, such as accounting and payment services, addressing issues like the 30% error rate in supply chain invoices. By organizing and analyzing complex, unstructured data, Loop enhances efficiency for clients, including 20% of the Fortune 100, enabling them to better serve their customers. (01:13:01) - Errik Anderson, founder and CEO of Alloy Therapeutics, discusses the company's role in providing biotech infrastructure to support drug discovery and development. He highlights the integration of AI and machine learning in accelerating drug development, emphasizing the importance of combining in silico simulations with wet lab experiments to validate findings. Anderson also notes the trend of big pharma acquiring innovations from smaller companies to replenish their pipelines as patents expire, underscoring the industry's need for efficient and collaborative drug development processes. (01:29:06) - Pippa Lamb is a Partner at Sweet Capital, an early-stage venture fund established by the founders of King.com (Candy Crush). In the conversation, she highlights the UK's robust AI ecosystem, emphasizing the country's deep R&D capabilities and the emergence of grassroots innovations from local universities. Lamb also notes the trend of European entrepreneurs relocating to London, reinforcing the city's status as a hub for ambitious founders. James Wise is a partner at Balderton Capital, a leading European venture firm, where he focuses on investing in early-stage technology companies across fintech, marketplaces, and software. He is known for backing high-growth startups and working closely with founders on scaling products and building category-defining businesses. (01:41:48) - 𝕏 Timeline Reactions Follow TBPN:  https://TBPN.com https://x.com/tbpn https://open.spotify.com/show/2L6WMqY3GUPCGBD0dX6p00?si=674252d53acf4231 https://podcasts.apple.com/us/podcast/technology-brothers/id1772360235 https://www.youtube.com/@TBPNLive
About TBPN
TBPN

TBPN

By John Coogan & Jordi Hays

Technology's daily show (formerly the Technology Brothers Podcast). Streaming live on X and YouTube from 11 - 2 PM PST Monday - Friday. Available on X, Apple, Spotify, and YouTube.